| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $221.9M | +2285.3% |
| Cost of Revenue | $3.9M | +58.5% |
| R&D Expense | $506.5M | +11.1% |
| SG&A Expense | $288.9M | +91.9% |
| Operating Income | -$593.0M | +2.4% |
| Interest Expense | $34.3M | -57.8% |
| Pre-tax Income | -$542.2M | +17.0% |
| Income Tax | $1.2M | — |
| Net Income | -$543.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $681.1M | +81.2% |
| Accounts Receivable | $4.7M | +169.7% |
| Current Assets | $720.7M | +50.9% |
| Total Assets | $919.3M | +68.3% |
| Current Liabilities | $154.4M | +7.3% |
| Long-term Debt | $437.3M | -2.0% |
| Total Liabilities | $2.38B | +25.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$520.7M | +1.3% |
| Capital Expenditures | $933K | -28.6% |
| Investing Cash Flow | $60.8M | +12.5% |
| Financing Cash Flow | $748.5M | +65.8% |
| Free Cash Flow | -$521.7M | +1.4% |
| +16.8% |
| EPS (Basic) | -$2.88 | +27.1% |
| EPS (Diluted) | -$2.88 | +27.1% |
| Stockholders' Equity |
| -$1.47B |
| -8.4% |